Suzhou Industrial Park Heshun Electric
300141
Guangdong Xiongsu Technology Group
300599
Sichuan Chuanhuan Technology
300547
Shanghai Wisdom Information Technology
301315
KANGNONG SEED
837403
CN Stock MarketDetailed Quotes
688513 Chengdu Easton Biopharmaceuticals
- 30.80
- +0.22+0.72%
Market Closed Dec 27 15:00 CST
5.44BMarket Cap21.75P/E (TTM)
30.98High30.36Low15.41KlotVolume30.63Open30.58Pre Close47.27MTurnover0.87%Turnover Ratio24.01P/E (Static)176.53MShares46.8452wk High2.03P/B5.44BFloat Cap28.1152wk Low36.70Limit Up176.53MShs Float58.35Historical High24.46Limit Down2.03%Amplitude26.96Historical Low0.40Dividend TTM30.68Avg Price8.68KlotAsk1.28%Div YieldTTM100Lot Size6.19KlotBid
Chengdu Easton Biopharmaceuticals Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 9.28%585.01M | 6.56%682.62M | 32.74%823.67M | -5.99%781.23M | -4.38%535.35M | 47.17%640.57M | 3.97%620.51M | -20.91%830.97M | 166.11%559.86M | 49.04%435.27M |
| Transactional financial assets | -6.39%824.18M | 17.05%851.13M | -10.35%663.97M | 43.66%741.78M | 14.93%880.46M | -17.30%727.13M | -9.16%740.65M | 13.78%516.36M | -44.26%766.08M | -29.94%879.19M |
| Notes receivable and accounts receivable | 66.80%250.94M | 91.04%228.64M | 18.97%174.14M | -6.14%134.27M | 4.70%150.45M | 8.76%119.68M | 48.65%146.37M | 20.55%143.06M | 13.54%143.7M | -13.50%110.04M |
| -Notes receivable | 114.46%17.9M | -8.73%7.14M | 38.26%12.78M | 130.29%14.09M | 35.80%8.35M | -14.09%7.83M | 129.99%9.24M | -2.09%6.12M | 132.39%6.15M | 75.08%9.11M |
| -Accounts receivable | 64.00%233.04M | 98.02%221.49M | 17.67%161.36M | -12.24%120.18M | 3.31%142.1M | 10.83%111.86M | 45.19%137.13M | 21.80%136.94M | 11.00%137.55M | -17.28%100.93M |
| Other receivables (including interest and dividends) | 11.98%705.01K | 505.40%2.59M | 38.10%1.2M | -47.18%659.83K | -74.35%629.6K | 10.32%427.38K | 101.19%872.19K | 630.83%1.25M | 671.58%2.45M | -12.26%387.41K |
| -Other receivable | ---- | 505.40%2.59M | ---- | -47.18%659.83K | ---- | 10.32%427.38K | ---- | 630.83%1.25M | ---- | -12.26%387.41K |
| Advance payment | 34.41%19.13M | 10.03%19.56M | -0.90%15.9M | -44.81%8.78M | 42.14%14.23M | 5.52%17.77M | -7.49%16.04M | -11.48%15.91M | -19.11%10.01M | 43.85%16.84M |
| Inventories | 13.91%184.33M | 12.69%183.47M | 11.92%174.53M | 14.28%160.98M | 30.72%161.81M | 29.13%162.8M | 28.72%155.94M | 35.86%140.87M | 37.76%123.78M | 40.41%126.08M |
| Receivable financing | 89.68%70.8M | 127.55%60.64M | 10.72%41.37M | 14.72%43.43M | -0.44%37.32M | -10.25%26.65M | 141.44%37.36M | 370.37%37.86M | 113.30%37.49M | 105.42%29.69M |
| Other current assets | -17.40%5.21M | 112.23%11.13M | -64.48%8.9M | -48.64%11.73M | -70.21%6.3M | -73.37%5.24M | 3.97%25.06M | -12.07%22.84M | 4.75%21.16M | -4.26%19.69M |
| Total current assets | 8.61%1.94B | 19.97%2.04B | 9.23%1.9B | 10.17%1.88B | 7.33%1.79B | 5.14%1.7B | 3.18%1.74B | -3.93%1.71B | -10.11%1.66B | -10.70%1.62B |
| Non Current assets | ||||||||||
| Other equity investment | 0.00%10M | --10M | --10M | --10M | --10M | ---- | ---- | ---- | ---- | ---- |
| Other non-current financial assets | 3.23%48M | 24.68%48M | 24.68%48M | 111.36%46.5M | 111.36%46.5M | 75.00%38.5M | 102.63%38.5M | --22M | --22M | --22M |
| Fixed assets | ---- | 8.35%1.03B | ---- | 17.46%1.07B | ---- | 27.62%950.5M | ---- | 284.37%909.85M | ---- | 256.46%744.79M |
| Constru in process | ---- | -8.61%219.98M | ---- | -19.42%186.19M | ---- | -8.71%240.7M | ---- | -63.76%231.06M | ---- | -45.97%263.68M |
| Construction materials | ---- | ---- | ---- | 22.99%64.25K | ---- | --63.19K | ---- | -79.73%52.24K | ---- | ---- |
| Intangible assets | -2.84%33.39M | -2.42%33.81M | -1.89%34.27M | -0.43%34.46M | 3.03%34.37M | 2.08%34.65M | 1.80%34.93M | 2.67%34.61M | -0.76%33.36M | 0.43%33.94M |
| Development expenditure | 48.50%68.21M | 40.46%63.38M | 35.06%58.95M | 17.92%50M | 28.87%45.93M | 76.33%45.13M | 170.24%43.65M | 426.87%42.4M | --35.64M | --25.59M |
| Long deferred expense | -32.34%3.7M | 72.21%4.07M | 68.63%4.44M | 66.25%4.92M | 65.95%5.47M | -34.86%2.36M | -33.59%2.63M | -31.14%2.96M | -22.95%3.29M | -15.98%3.62M |
| Deferred tax assets | 82.38%11.95M | 44.44%9.44M | 19.95%8.25M | -1.84%8.57M | -18.71%6.55M | -31.38%6.53M | -36.22%6.88M | -28.18%8.73M | -23.88%8.06M | 9.45%9.52M |
| Other non current assets | -37.91%24.4M | -22.82%32.45M | -36.07%26.3M | -6.87%29.89M | 0.78%39.29M | -61.56%42.04M | -64.20%41.14M | -49.37%32.09M | 25.17%38.99M | 325.00%109.37M |
| Total non current assets | 3.39%1.48B | 6.44%1.47B | 8.46%1.47B | 11.88%1.46B | 6.76%1.43B | 7.71%1.39B | 15.63%1.36B | 31.34%1.31B | 50.69%1.34B | 67.12%1.29B |
| Total assets | 6.29%3.42B | 13.89%3.51B | 8.89%3.37B | 10.91%3.35B | 7.08%3.22B | 6.28%3.09B | 8.28%3.1B | 8.73%3.02B | 9.60%3B | 12.50%2.9B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -3.97%125.89M | 60.45%210.32M | 29.23%161.09M | 71.85%180.95M | -7.03%131.1M | 8.92%131.08M | 149.05%124.65M | 425.87%105.29M | --141.01M | --120.34M |
| Notes payable and accounts payable | 4.18%163.73M | 11.29%188.48M | 5.26%174.9M | 15.35%180.94M | -9.27%157.16M | -7.02%169.36M | -20.66%166.16M | -23.08%156.86M | -21.93%173.22M | 16.88%182.14M |
| -Notes payable | 6.54%39.8M | -12.39%46.58M | 1.03%43.68M | 398.21%45.8M | 19.20%37.35M | 85.70%53.17M | 8.71%43.24M | -79.99%9.19M | -39.83%31.34M | -29.20%28.63M |
| -Accounts payable | 3.45%123.94M | 22.12%141.9M | 6.75%131.21M | -8.48%135.14M | -15.56%119.81M | -24.31%116.19M | -27.55%122.92M | -6.52%147.67M | -16.44%141.88M | 33.03%153.51M |
| Contract liabilities | 27.51%36.21M | 96.50%35.02M | 111.24%44.22M | 11.40%31.98M | 15.63%28.4M | -1.77%17.82M | 29.22%20.93M | 161.15%28.71M | 132.65%24.56M | 128.34%18.15M |
| Salaries payable | 1.80%38.22M | -8.69%32.34M | -34.80%26.72M | -9.92%49.97M | -17.68%37.54M | 3.26%35.42M | 46.65%40.99M | 26.70%55.47M | 4.39%45.61M | 18.69%34.3M |
| Taxs payable | 56.03%34.89M | 87.14%31.34M | 63.12%22.71M | 7.86%15.87M | -0.16%22.36M | -15.00%16.74M | -15.58%13.92M | -12.28%14.71M | 1.65%22.4M | 22.82%19.7M |
| Other payable (including interest and dividends) | 39.57%247.15M | 63.23%262.46M | 29.95%225.84M | 21.20%195.94M | 15.50%177.08M | 14.55%160.79M | 22.72%173.8M | 22.83%161.67M | 9.38%153.31M | 2.67%140.37M |
| -Dividend payable | ---- | --29.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other payable | ---- | 44.81%232.83M | ---- | 21.20%195.94M | ---- | 14.55%160.79M | ---- | 22.83%161.67M | ---- | 2.67%140.37M |
| Non current liabilities due within one year | --2.93M | --2.93M | --2.93M | --2.93M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current liabilities | 228.27%13.55M | 81.13%4.64M | 45.05%8.25M | -62.31%2.51M | 6.64%4.13M | -57.03%2.56M | 81.46%5.69M | 24.67%6.67M | 29.34%3.87M | -3.96%5.96M |
| Total current liabilities | 18.79%662.57M | 43.79%767.53M | 22.07%666.67M | 24.88%661.09M | -1.10%557.77M | 2.46%533.77M | 17.48%546.13M | 22.41%529.39M | 27.79%563.97M | 48.15%520.96M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | 42.11%2.62M | 93.15%2.41M | 74.83%1.79M | 65.06%1.46M | 32.95%1.84M | -12.12%1.25M | 46.83%1.02M | 665.62%882.64K | 41.99%1.39M | 19.85%1.42M |
| Long term deferred income | -6.91%37.85M | -4.44%39M | -12.33%40.16M | -3.80%41.18M | -8.78%40.66M | -13.80%40.81M | -9.09%45.82M | -16.10%42.81M | -13.61%44.57M | -6.01%47.34M |
| Total non current liabilities | -9.14%78.63M | 89.13%79.54M | 74.19%81.59M | 88.22%82.24M | 88.28%86.54M | -13.75%42.05M | -8.33%46.84M | -14.57%43.69M | -12.57%45.96M | -5.41%48.76M |
| Total liabilities | 15.04%741.2M | 47.10%847.07M | 26.19%748.26M | 29.71%743.33M | 5.64%644.31M | 1.07%575.82M | 14.93%592.97M | 18.50%573.08M | 23.50%609.93M | 41.30%569.71M |
| Shareholders equity | ||||||||||
| Paid-in capital | 47.00%176.53M | 47.00%176.53M | 0.00%120.09M | 0.00%120.09M | 0.00%120.09M | 0.00%120.09M | 0.00%120.09M | 0.00%120.09M | 0.00%120.09M | 0.00%120.09M |
| Capital reserve funds | -4.39%1.38B | -4.98%1.37B | 0.02%1.44B | 0.02%1.44B | 0.00%1.44B | 0.00%1.44B | 0.00%1.44B | 0.00%1.44B | 0.00%1.44B | 0.00%1.44B |
| Surplus reserve funds | 0.00%60.05M | 0.00%60.05M | 0.00%60.05M | 0.00%60.05M | 0.00%60.05M | 0.00%60.05M | 0.00%60.05M | 0.00%60.05M | 32.25%60.05M | 32.25%60.05M |
| Retained profit | 19.04%1.13B | 19.43%1.06B | 19.67%1.05B | 19.42%979.58M | 23.07%946.72M | 24.87%884.53M | 22.19%881.25M | 22.90%820.26M | 21.01%769.23M | 24.94%708.37M |
| Less:Treasury stock | 13,104.68%69.45M | --4.58K | --54.31M | --1.59M | --525.95K | ---- | ---- | ---- | ---- | ---- |
| Specific reserves | 74.13%2.23M | 113.35%1.92M | 281.54%1.39M | 5,799.71%989.86K | 939.12%1.28M | -4.00%898.71K | -18.03%363.5K | -76.81%16.78K | -89.37%123.45K | 9.69%936.14K |
| Shareholders equity without minority interests | 4.10%2.68B | 6.27%2.67B | 4.80%2.63B | 6.50%2.6B | 7.44%2.57B | 7.55%2.51B | 6.82%2.51B | 6.67%2.44B | 6.55%2.39B | 7.17%2.33B |
| Total shareholder equity | 4.10%2.68B | 6.27%2.67B | 4.80%2.63B | 6.50%2.6B | 7.44%2.57B | 7.55%2.51B | 6.82%2.51B | 6.67%2.44B | 6.55%2.39B | 7.17%2.33B |
| Total liabilityies and equity | 6.29%3.42B | 13.89%3.51B | 8.89%3.37B | 10.91%3.35B | 7.08%3.22B | 6.28%3.09B | 8.28%3.1B | 8.73%3.02B | 9.60%3B | 12.50%2.9B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
